U.S. Markets close in 5 hrs 47 mins

Sanofi (SNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
50.31-0.31 (-0.61%)
As of 10:13AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close50.62
Open50.56
Bid50.25 x 1300
Ask50.30 x 3100
Day's Range50.16 - 50.56
52 Week Range37.62 - 55.00
Volume77,541
Avg. Volume1,130,414
Market Cap126.539B
Beta (5Y Monthly)0.40
PE Ratio (TTM)25.93
EPS (TTM)1.94
Earnings DateN/A
Forward Dividend & Yield1.70 (3.36%)
Ex-Dividend DateApr 30, 2020
1y Target Est61.38
  • Reuters

    Sanofi to publish COVID-19 vaccine price in development with GSK after Phase I/II trial results

    French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday. The company is expected to release the results from the Phase I/II clinical trials this month. It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.

  • Is Moderna Stock A Buy As It Seeks Authorization For Its Covid Vaccine?
    Investor's Business Daily

    Is Moderna Stock A Buy As It Seeks Authorization For Its Covid Vaccine?

    Moderna has emerged as a strong competitor in the race for a coronavirus vaccine. But Moderna stock remains on a wild ride in 2020 as the need for a Covid-19 vaccine grows.

  • GlobeNewswire

    Sanofi: Information concerning the total number of voting rights and shares - October 2020

    Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)Sanofi a French société anonyme with a registered share capital of 2,517,873,886 € Registered office : 54, rue La Boétie – 75008 Paris – France Registered at the Paris Commercial and Companies Registry under number 395 030 844Date   Total number of issued shares   Number of real voting rights (excluding treasury shares) Theoretical number of voting rights (including treasury shares)* October 31, 2020 1,258,964,700 1,411,078,975 1,413,674,734 *  Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.This information is also available on the internet website of sanofi under « Regulated Information in France »:https://www.sanofi.com/en/investors/sanofi-share-and-adrs/share-overview/shares-and-voting-rights/Investor Relations Department Europe Tel: + 33 1 53 77 45 45           US Tel: + 1 908 981 5560 e-mail: IR@sanofi.com   Media Relations Department Tel: + 33 1 53 77 46 46  e-mail: MR@sanofi.com    Attachment * EN_number_of_shares_and_voting_rights_October_2020